LIFEMD INC - LFMD 8 7/8 PERP (LFMDP) Stock Fundamental Analysis

NASDAQ:LFMDP • US53216B2034

22.75 USD
+0.05 (+0.22%)
Last: Feb 20, 2026, 08:00 PM
Fundamental Rating

4

Overall LFMDP gets a fundamental rating of 4 out of 10. We evaluated LFMDP against 35 industry peers in the Health Care Technology industry. While LFMDP seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, LFMDP is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year LFMDP has reported negative net income.
  • LFMDP had a positive operating cash flow in the past year.
  • LFMDP had negative earnings in each of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: LFMDP reported negative operating cash flow in multiple years.
LFMDP Yearly Net Income VS EBIT VS OCF VS FCFLFMDP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

  • LFMDP's Return On Assets of -11.68% is in line compared to the rest of the industry. LFMDP outperforms 54.29% of its industry peers.
  • LFMDP's Return On Equity of -586.53% is on the low side compared to the rest of the industry. LFMDP is outperformed by 88.57% of its industry peers.
  • The Return On Invested Capital of LFMDP (5.81%) is better than 85.71% of its industry peers.
Industry RankSector Rank
ROA -11.68%
ROE -586.53%
ROIC 5.81%
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LFMDP Yearly ROA, ROE, ROICLFMDP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

1.3 Margins

  • LFMDP's Operating Margin of 0.27% is in line compared to the rest of the industry. LFMDP outperforms 60.00% of its industry peers.
  • Looking at the Gross Margin, with a value of 86.96%, LFMDP belongs to the top of the industry, outperforming 88.57% of the companies in the same industry.
  • In the last couple of years the Gross Margin of LFMDP has grown nicely.
Industry RankSector Rank
OM 0.27%
PM (TTM) N/A
GM 86.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
LFMDP Yearly Profit, Operating, Gross MarginsLFMDP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), LFMDP is destroying value.
  • Compared to 1 year ago, LFMDP has more shares outstanding
  • LFMDP has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, LFMDP has an improved debt to assets ratio.
LFMDP Yearly Shares OutstandingLFMDP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
LFMDP Yearly Total Debt VS Total AssetsLFMDP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • LFMDP has an Altman-Z score of 8.48. This indicates that LFMDP is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of LFMDP (8.48) is better than 85.71% of its industry peers.
  • LFMDP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.48
ROIC/WACC0.61
WACC9.58%
LFMDP Yearly LT Debt VS Equity VS FCFLFMDP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

  • A Current Ratio of 0.73 indicates that LFMDP may have some problems paying its short term obligations.
  • The Current ratio of LFMDP (0.73) is worse than 85.71% of its industry peers.
  • A Quick Ratio of 0.66 indicates that LFMDP may have some problems paying its short term obligations.
  • LFMDP has a Quick ratio of 0.66. This is amonst the worse of the industry: LFMDP underperforms 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 0.73
Quick Ratio 0.66
LFMDP Yearly Current Assets VS Current LiabilitesLFMDP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 78.13% over the past year.
  • Looking at the last year, LFMDP shows a very strong growth in Revenue. The Revenue has grown by 30.71%.
  • Measured over the past years, LFMDP shows a very strong growth in Revenue. The Revenue has been growing by 76.23% on average per year.
EPS 1Y (TTM)78.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)30.71%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%12.7%

3.2 Future

  • Based on estimates for the next years, LFMDP will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.36% on average per year.
  • Based on estimates for the next years, LFMDP will show a small growth in Revenue. The Revenue will grow by 3.16% on average per year.
EPS Next Y61.09%
EPS Next 2Y37.18%
EPS Next 3Y34.41%
EPS Next 5Y18.36%
Revenue Next Year15.11%
Revenue Next 2Y4.37%
Revenue Next 3Y8.63%
Revenue Next 5Y3.16%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LFMDP Yearly Revenue VS EstimatesLFMDP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M 250M
LFMDP Yearly EPS VS EstimatesLFMDP Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -0.5 -1 -1.5 -2

2

4. Valuation

4.1 Price/Earnings Ratio

  • LFMDP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LFMDP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LFMDP Price Earnings VS Forward Price EarningsLFMDP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as LFMDP.
  • LFMDP's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 4433.95
EV/EBITDA 91.54
LFMDP Per share dataLFMDP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as LFMDP's earnings are expected to grow with 34.41% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.18%
EPS Next 3Y34.41%

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 9.75%, LFMDP is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.59, LFMDP pays a better dividend. On top of this LFMDP pays more dividend than 97.14% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, LFMDP pays a better dividend.
Industry RankSector Rank
Dividend Yield 9.75%

5.2 History

  • LFMDP has been paying a dividend for over 5 years, so it has already some track record.
  • The dividend of LFMDP decreased recently.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
LFMDP Yearly Dividends per shareLFMDP Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • LFMDP has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-40.3%
EPS Next 2Y37.18%
EPS Next 3Y34.41%
LFMDP Yearly Income VS Free CF VS DividendLFMDP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

LIFEMD INC - LFMD 8 7/8 PERP

NASDAQ:LFMDP (2/20/2026, 8:00:01 PM)

22.75

+0.05 (+0.22%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-17
Earnings (Next)03-16
Inst Owners43.01%
Inst Owner ChangeN/A
Ins Owners17.81%
Ins Owner ChangeN/A
Market Cap1.10B
Revenue(TTM)252.34M
Net Income(TTM)-7.71M
Analysts81.43
Price Target65.53 (188.04%)
Short Float %0%
Short Ratio0.43
Dividend
Industry RankSector Rank
Dividend Yield 9.75%
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP-40.3%
Div Incr Years0
Div Non Decr Years1
Ex-Date01-05
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-341.17%
Min EPS beat(2)-635.29%
Max EPS beat(2)-47.05%
EPS beat(4)2
Avg EPS beat(4)-125.48%
Min EPS beat(4)-635.29%
Max EPS beat(4)118.55%
EPS beat(8)3
Avg EPS beat(8)-71.45%
EPS beat(12)4
Avg EPS beat(12)-68.84%
EPS beat(16)5
Avg EPS beat(16)-56.76%
Revenue beat(2)0
Avg Revenue beat(2)-6.5%
Min Revenue beat(2)-8.06%
Max Revenue beat(2)-4.95%
Revenue beat(4)2
Avg Revenue beat(4)-0.06%
Min Revenue beat(4)-8.06%
Max Revenue beat(4)9.78%
Revenue beat(8)5
Avg Revenue beat(8)1.29%
Revenue beat(12)7
Avg Revenue beat(12)-0.23%
Revenue beat(16)7
Avg Revenue beat(16)-1.53%
PT rev (1m)32.88%
PT rev (3m)-3.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)13.04%
EPS NY rev (1m)0%
EPS NY rev (3m)-50.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-22.99%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.47%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.34
P/FCF 4433.95
P/OCF 83.42
P/B 833.22
P/tB N/A
EV/EBITDA 91.54
EPS(TTM)-0.14
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)0.01
FCFY0.02%
OCF(TTM)0.27
OCFY1.2%
SpS5.24
BVpS0.03
TBVpS-0.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -11.68%
ROE -586.53%
ROCE 7.35%
ROIC 5.81%
ROICexc N/A
ROICexgc N/A
OM 0.27%
PM (TTM) N/A
GM 86.96%
FCFM 0.1%
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
F-Score5
Asset Turnover3.82
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 116.91%
Cap/Sales 5.1%
Interest Coverage 0.33
Cash Conversion 112.17%
Profit Quality N/A
Current Ratio 0.73
Quick Ratio 0.66
Altman-Z 8.48
F-Score5
WACC9.58%
ROIC/WACC0.61
Cap/Depr(3y)162.46%
Cap/Depr(5y)195.18%
Cap/Sales(3y)6.18%
Cap/Sales(5y)4.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y61.09%
EPS Next 2Y37.18%
EPS Next 3Y34.41%
EPS Next 5Y18.36%
Revenue 1Y (TTM)30.71%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%12.7%
Revenue Next Year15.11%
Revenue Next 2Y4.37%
Revenue Next 3Y8.63%
Revenue Next 5Y3.16%
EBIT growth 1Y103.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year237.85%
EBIT Next 3Y55.58%
EBIT Next 5Y43.22%
FCF growth 1Y103.53%
FCF growth 3YN/A
FCF growth 5Y88.7%
OCF growth 1Y1051.68%
OCF growth 3YN/A
OCF growth 5Y133.93%

LIFEMD INC - LFMD 8 7/8 PERP / LFMDP FAQ

What is the ChartMill fundamental rating of LIFEMD INC - LFMD 8 7/8 PERP (LFMDP) stock?

ChartMill assigns a fundamental rating of 4 / 10 to LFMDP.


Can you provide the valuation status for LIFEMD INC - LFMD 8 7/8 PERP?

ChartMill assigns a valuation rating of 2 / 10 to LIFEMD INC - LFMD 8 7/8 PERP (LFMDP). This can be considered as Overvalued.


What is the profitability of LFMDP stock?

LIFEMD INC - LFMD 8 7/8 PERP (LFMDP) has a profitability rating of 3 / 10.


What is the earnings growth outlook for LIFEMD INC - LFMD 8 7/8 PERP?

The Earnings per Share (EPS) of LIFEMD INC - LFMD 8 7/8 PERP (LFMDP) is expected to grow by 61.09% in the next year.